Raymond James Financial Services Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,530
| Closed | -$19.9K | – | 3497 |
|
|
2024
Q2 | $19.9K | Sell |
14,530
-10,830
| -43% | -$14.8K | ﹤0.01% | 3330 |
|
|
2024
Q1 | $95.1K | Buy |
25,360
+4,578
| +22% | +$17.2K | ﹤0.01% | 3224 |
|
|
2023
Q4 | $204K | Buy |
20,782
+8,168
| +65% | +$80.1K | ﹤0.01% | 2975 |
|
|
2023
Q3 | $105K | Buy |
+12,614
| New | +$105K | ﹤0.01% | 3046 |
|
|
2021
Q3 | – | Sell |
-7,556
| Closed | -$264K | – | 3311 |
|
|
2021
Q2 | $264K | Sell |
7,556
-4,947
| -40% | -$173K | ﹤0.01% | 2804 |
|
|
2021
Q1 | $416K | Buy |
+12,503
| New | +$416K | ﹤0.01% | 2408 |
|